Costs of HPV vaccination programs in low- and middle-income countries: A systematic review.
J Cancer PolicyJun 26, 2026 (epub)
Tianjiao Gao, Polydor M Kabila, Karima Chiuri et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review examined the costs associated with HPV vaccination programs in low- and middle-income countries (LMICs), analyzing 19 articles from 26 countries. The cost per dose varied significantly, ranging from $6.66 to $82.78 for economic costs. Understanding these costs is vital for optimizing vaccination program effectiveness in LMICs.
Key findings
- Cost per dose ranged from $6.66 to $82.78 for economic costs in 2023 USD.
- Financial costs per dose varied from $5.69 to $51.21 in 2023 USD.
- 16 of the 26 countries studied were located in Africa, with most programs initiated in the 2010s.
- Significant variation in primary cost drivers was reported across different studies.
Why it matters
Understanding the costs and cost drivers of HPV vaccination programs is crucial for policymakers in LMICs. This knowledge can help optimize resource allocation and improve program implementation, ultimately enhancing public health outcomes related to cervical cancer prevention.